Cargando…

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers

SLPI has been implicated in the progression and metastasis of certain cancers. However, the effects of SLPI seem to be tumor-specific and the mechanisms remain poorly defined. Here, we demonstrate that highly metastatic, triple-negative breast cancer (TNBC) 4T1 cells secreted more SLPI compared to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozin, Sergey V., Maimon, Nir, Wang, Rong, Gupta, Nisha, Munn, Lance, Jain, Rakesh K., Garkavtsev, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752445/ https://www.ncbi.nlm.nih.gov/pubmed/29312532 http://dx.doi.org/10.18632/oncotarget.22660

Ejemplares similares

SLPI: a new target for stopping metastasis
por: Munn, Lance L., et al.
Publicado: (2018)

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
por: Dickey, Brittney L., et al.
Publicado: (2021)

Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
por: Wex, Thomas, et al.
Publicado: (2011)

Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
por: Sayers, Kevin T., et al.
Publicado: (2014)

Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2022)

Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate
por: Baranger, Kévin, et al.
Publicado: (2011)

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
por: Lange, Anna, et al.
Publicado: (2019)

Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury
por: Kongpol, Kantapich, et al.
Publicado: (2019)

Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells
por: Wei, Zhijiang, et al.
Publicado: (2023)

Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
por: Nyström, M, et al.
Publicado: (1999)

Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT
por: Wei, Zhijiang, et al.
Publicado: (2020)

Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2021)

IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
por: Westin, U, et al.
Publicado: (1998)

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022)

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020)

Secretory Leukocyte Protease Inhibitor (SLPI)—A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study
por: Averdunk, Luisa, et al.
Publicado: (2019)

Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury
por: Pikwong, Faprathan, et al.
Publicado: (2023)

Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer
por: Liu, Guiying, et al.
Publicado: (2014)

Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient Mice
por: Nakamura, Akira, et al.
Publicado: (2003)

How SLPI soothes
por: Van Epps, Heather L.
Publicado: (2005)

Determinants of Leukocyte Margination in Rectangular Microchannels
por: Jain, Abhishek, et al.
Publicado: (2009)

Immunoregulatory role of secretory leukocyte protease inhibitor in allergic asthma
por: Marino, Rafael, et al.
Publicado: (2010)

Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models
por: Gupta, Nisha, et al.
Publicado: (2023)

Effect of Semen on Vaginal Fluid Cytokines and Secretory Leukocyte Protease Inhibitor
por: Agnew, Kathy J., et al.
Publicado: (2008)

Cripto-1 as a novel therapeutic target for triple negative breast cancer
por: Castro, Nadia P., et al.
Publicado: (2014)

Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2
por: Yin, Lei, et al.
Publicado: (2010)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017)

c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors
por: Flanagan, Kevin C., et al.
Publicado: (2017)

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
por: Nyström, M, et al.
Publicado: (2001)

Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
por: Nugteren, Sandrine, et al.
Publicado: (2022)

Secretory Leukoprotease Inhibitor (Slpi) Expression Is Required for Educating Murine Dendritic Cells Inflammatory Response Following Quercetin Exposure
por: De Santis, Stefania, et al.
Publicado: (2017)

Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk
por: Walsh, Kyle M., et al.
Publicado: (2015)

SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3
por: Tripathi, Utkarsh, et al.
Publicado: (2021)

Cementoin–SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI
por: Maffía, Paulo C., et al.
Publicado: (2018)

Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex
por: Sullivan, Anita L, et al.
Publicado: (2008)

Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis
por: Reviglio, Victor E., et al.
Publicado: (2007)

Human papillomavirus infection in head and neck cancer: The role of the secretory leukocyte protease inhibitor
por: HOFFMANN, MARKUS, et al.
Publicado: (2013)

The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury
por: Prompunt, Eakkapote, et al.
Publicado: (2018)

Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis
por: Sawicki, Konrad Teodor, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kkqplulc3rjbc5thtrjaaiukqj